Wire Stories

Enfusion Names Michael Spellacy as Board Chair and Non-Executive Director

NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-native software-as-a-service (SaaS) solutions…

3 years ago

Cardiovascular Systems, Inc. Enrolls First Patient in Japan for Kaizen Clinical Study

KAIZEN to assess safety and efficacy of peripheral orbital atherectomy to secure regulatory approval in Japan ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular…

3 years ago

Five Year Agreement with Brown-Forman Includes Old Forester, Finlandia and Herradura LOUISVILLE, Ky., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Churchill…

3 years ago

SPIE, the International Society for Optics and Photonics, Announces Its 2023 Society Awards

The 21 award recipients represent an exciting range of stellar achievements across light-based sciences and technologies BELLINGHAM, Wash.--(BUSINESS WIRE)--The Awards…

3 years ago

Global Toxicity Testing Outsourcing Market Report to 2028: Increased Efficiency in Drug Discovery and Personalized Therapy Drives Growth – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Toxicity Testing Outsourcing Market Size, Share & Industry Trends Analysis Report by End-use, Method, GLP, Regional Outlook…

3 years ago

Graphene-enhanced Composites Global Market Report 2022: Low Cost Compared to Metal Drives Demand – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Graphene-enhanced Composites Market-Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Composite Type, By Graphene Type,…

3 years ago

RUTHERFORD, N.J., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ: BLFY) (the �Company�), the holding company for Blue…

3 years ago

MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTC Pink: PPCB) (�Propanc� or the �Company�), a biopharmaceutical company developing novel cancer treatments for…

3 years ago

LAS VEGAS--(BUSINESS WIRE)--Lakeside Lightning Semiconductor (LLS), an OLED microdisplay manufacturer based in Jiangsu, China, announced at the International Consumer Electronics…

3 years ago

� EXKIVITY is the First Category-1 Innovative Drug Approved for Takeda China Following a Phase 2 Global Pivotal Study �…

3 years ago